반응식
C1COCC1.CCN(CC)CC.[C:13]1([CH3:22])[CH:18]=[CH:17][C:16]([C:19](Cl)=O)=[CH:15][CH:14]=1.[CH2:23]([O:26][CH:27]1[CH2:32][CH2:31][CH2:30][CH2:29][O:28]1)[C:24]#[CH:25].Cl.[C:34]1([CH2:40][C:41]([NH2:43])=[NH:42])[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=1.C([O-])([O-])=O.[Na+].[Na+]>C1COCC1.CO.CCOCC.Cl[Pd](Cl)([P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.[Cu]I.CO>[CH2:40]([C:41]1[N:43]=[C:24]([CH2:23][O:26][CH:27]2[CH2:32][CH2:31][CH2:30][CH2:29][O:28]2)[CH:25]=[C:19]([C:16]2[CH:17]=[CH:18][C:13]([CH3:22])=[CH:14][CH:15]=2)[N:42]=1)[C:34]1[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=1참가 물질
반응물 6
생성물 1
시약·촉매·용매 5
실험 절차
To a solution of Pd(PPh3)2Cl2 (0.285 g, 0.41 mmol) and CuI in THF (50 mL) (0.148 g, 0.777 mmol) was added Et3N (1.5 mL, 11.0 mmol), p-toluoyl chloride (1.3 mL, 10.0 mmol) and tetrahydro-2-(2-propynyloxy)-2H-pyran (1.4 mL, 10.0 mmol). After stirring for 2.5 h, a solution of 2-phenylacetamidine hydrochloride (2.0 g, 11.7 mmol) in THF/MeOH (1:1, 10 mL) was added followed by additional MeOH (5 mL) and Na2CO3 (3.2 g, 30.0 mmol). The reaction mixture was heated at reflux for 15 h, cooled to rt, diluted with Et2O and filtered through a small pad of diatomaceous earth. The filtrate was concentrated and purified via SiO2 chromatography (10-45% EtOAc/hexanes) to give 2.0 g (53%) of the title compound. 1H NMR (CDCl3): 8.02-8.00 (m, 2H), 7.68 (s, 1H), 7.46-7.44 (m, 2H), 7.30-7.27 (m, 4H), 7.21-7.19 (m, 1H), 4.87 (d, J=14.7, 1H), 4.77 (t, J=3.5, 1H), 4.62 (d, J=15.1, 1H), 4.31 (s, 2H), 3.91-3.86 (m, 1H), 3.57-3.52 (m, 1H), 2.41 (s, 3H), 1.96-1.87 (m, 1H), 1.84-1.72 (m, 2H), 1.66-1.55 (m, 3H).
후처리
- temperatureThe reaction mixture was heated
- temperatureat reflux for 15 h
- filtrationfiltered through a small pad of diatomaceous earth
- concentrationThe filtrate was concentrated
- custompurified via SiO2 chromatography (10-45% EtOAc/hexanes)
출처 및 근거
- ORD 기록
- ord-8f11950a520e4c4fa8cf10a40a966e78
- 출처 데이터셋
- uspto-grants-2013_12
- 특허 번호
- US08618288B2
연결된 노트
불러오는 중…